KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

B&G Foods (BGS) Asset Writedowns and Impairment (2016 - 2026)

B&G Foods' Asset Writedowns and Impairment history spans 12 years, with the latest figure at $27.8 million for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment fell 91.31% year-over-year to $27.8 million; the TTM value through Sep 2025 reached $688.3 million, up 98.12%, while the annual FY2026 figure was $28.5 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $27.8 million at B&G Foods, down from $320.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $320.0 million in Q3 2024 and bottomed at $2.8 million in Q4 2022.
  • The 4-year median for Asset Writedowns and Impairment is $27.8 million (2025), against an average of $114.1 million.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 96.04% in 2023 before it surged 7704.88% in 2024.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $2.8 million in 2022, then soared by 629.8% to $20.5 million in 2023, then skyrocketed by 1460.98% to $320.0 million in 2024, then plummeted by 91.31% to $27.8 million in 2025.
  • Per Business Quant, the three most recent readings for BGS's Asset Writedowns and Impairment are $27.8 million (Q3 2025), $320.0 million (Q4 2024), and $320.0 million (Q3 2024).